Mikael Ørum
Chairman
Pharmaceuticals
rhovac
Sweden
Biography
Mikael Ørum studied banking, finance and law at the Copenhagen Business College, the Danish Bankers Academy, Copenhagen Business School, and the University of Copenhagen. Mr. Ørum is Chair of RhoVac ApS since 2014, and of RhoVac AB since its establishment in 2015. With more than 35 years' experience in the biotech and finance sectors, Mr. Ørum has participated in the development and implementation of several strategic business plans and has experience in raising capital and international business. He is a founder and partner in Ventac Partners. He has also participated in establishing several successful biotech companies including Exiqon, Santaris Pharma and Avexxin AS, Norway, in which he has held the position of CEO and Board Chair since 2005. He is a part-owner in Ventac Holdings (Cyprus) Ltd., which owns shares in RhoVac.
Research Interest
finance and law
